Clinical Trials Directory

Trials / Conditions / Cerebrospinal Fluid Leak

Cerebrospinal Fluid Leak

15 registered clinical trials studyying Cerebrospinal Fluid Leak2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSafety and Efficacy Evaluation of ArtiFix® Sealant Graft in Subjects Requiring Dural Repair Following Neurosur
NCT07092267
Nurami Medical LtdN/A
Not Yet RecruitingEffect of Spinal Needle Type on Optic Nerve Sheath Diameter
NCT06497634
Bagcilar Training and Research HospitalN/A
CompletedEvaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surg
NCT04086550
Polyganics BVN/A
CompletedSuturable DuraGen™ PMCF Study
NCT04923867
Integra LifeSciences Corporation
WithdrawnAcetazolamide for the Prevention of Post Operative CSF Leak
NCT04351061
University of MiamiPhase 2
CompletedA Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Comme
NCT04145544
Nurami Medical LtdN/A
UnknownThe Efficacy and Safety of a Latest Dural Substitute
NCT04490629
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
CompletedPost-market Assessment of Biodesign Dural Repair Grafts
NCT04057157
Cook Research Incorporated
CompletedPerioperative CSF Leak Management - an Opinion Study
NCT04124523
University Hospital, Montpellier
CompletedEvaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial S
NCT03566602
Polyganics BVN/A
WithdrawnSphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
NCT03181464
Washington University School of MedicinePhase 4
CompletedEfficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
NCT02891070
Baxter Healthcare CorporationPhase 3
WithdrawnAcetazolamide to Prevent Post Operative CSF Leak
NCT02902133
University of MiamiPhase 2
UnknownMobilisation Algorithm After Incidental Durotomy
NCT02927782
Balgrist University HospitalN/A
CompletedThe EVICEL® Neurosurgery Phase III Study
NCT02457546
Ethicon, Inc.Phase 3